EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Désirée van der Heijde, Maxime Dougados et al.|Annals of the Rheumatic Diseases|2020Cited by 2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateJosef S Smolen, Désirée van der Heijde, Robert Landewé et al.|Annals of the Rheumatic Diseases|2022Cited by 1.9k